The current PE ratio for Astrazeneca stock as of May 10, 2024 is 37.65. This is calculated based on the TTM EPS of $2.05 and the stock price of $77.18 per share. The PE ratio marks an increase of 8% from its last 4 quarters average of 34.9.
The average historical PE ratio of Astrazeneca for the last ten years is 85.02. The current P/E ratio of 37.65 is 56% lower than the historical average. Looking back at the last ten years, AZN's PE ratio peaked in the Dec 2021 quarter at 1,456.25, when the price was $58.25 and the EPS was $0.04. The lowest point was in the Dec 2016 quarter, when it reached 19.65 with a price of $27.32 and an EPS of $1.39.
Maximum annual increase: 3,453.56% in 2021
Maximum annual decrease: -95.61% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 35.08 | -45.15% |
| 2022 | 63.96 | -95.61% |
| 2021 | 1,456.25 | 3,453.56% |
| 2020 | 40.98 | -57.26% |
| 2019 | 95.88 | 114.59% |
| 2018 | 44.68 | 53.22% |
| 2017 | 29.16 | 48.4% |
| 2016 | 19.65 | -35.17% |
| 2015 | 30.31 | -57.8% |
| 2014 | 71.82 | 146.8% |
Currently, AZN's PE ratio is lower than its 3, 5 and 10-year averages.
In comparison to its peers LLY and MRK, AZN's PE ratio is lower, but it is higher than JNJ's and NVS's. Astrazeneca's PE ratio is trading above the peer average of 20.89.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 9.82 | $360.79B |
| NVS Novartis AG | 13.78 | $208.32B |
| BIIB Biogen Inc | 27.52 | $32.25B |
| ABT Abbott Laboratories | 32.43 | $182.21B |
| AZN Astrazeneca plc | 37.65 | $239.28B |
| LLY ELI LILLY & Co | 111.44 | $722.31B |
| MRK Merck & Co Inc | 142.92 | $329.42B |
| PFE Pfizer Inc | N/A | $158.72B |
| BMY Bristol Myers Squibb Co | N/A | $91.1B |
AZN stock has a price to earnings ratio of 37.65 as of May 10, 2024.
The 3-year average price to earnings ratio for AZN stock is 193.74.
The 5-year average price to earnings ratio for AZN stock is 133.84.
Over the last ten years, the quarterly PE ratio reached its highest level at 1,456.25 in the Dec 2021 quarter.
The current PE ratio of AZN is 56% lower than the 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (May 10, 2024), Astrazeneca's share price is $77.18. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $2.05. Therefore, Astrazeneca's PE ratio for today is 37.65. PE RATIO(37.65) = STOCK PRICE($77.18) / TTM EPS($2.05)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.